Paper39794860
Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021.
Li T and 8 others. J Hematol Oncol, 2025. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. Papers, record 39794860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39794860
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Uterine Cervical Neoplasms | Major topic |
| Ovarian Neoplasms | Major topic |
| Breast Neoplasms | Major topic |
| Uterine Neoplasms | Major topic |
| Humans | |
| Female | |
| Risk Factors | |
| Global Burden of Disease | |
| Global Health | |
| Incidence | |
| Middle Aged | |
| Adult | |
| Disability-Adjusted Life Years | |
| Aged |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023M743016 | China Postdoctoral Science Foundation | PubMed | ||
| 2022M722766 | China Postdoctoral Science Foundation | PubMed | ||
| 82403929 | National Natural Science Foundation of China | PubMed | ||
| LQ24H160007 | Natural Science Foundation of Zhejiang Province | PubMed | ||
| GZB20230642 | Postdoctoral Fellowship Program of CPSF | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36878567 | Updates on cervical cancer prevention. | Int J Gynecol Cancer | 2023 | https://conductscience.org/library/papers/36878567 | PubMed |
| 2 | 37641116 | Recent advances in targeted strategies for triple-negative breast cancer. | J Hematol Oncol | 2023 | https://conductscience.org/library/papers/37641116 | PubMed |
| 3 | 26546245 | Active and passive smoking and risk of breast cancer: a meta-analysis. | Breast Cancer Res Treat | 2015 | https://conductscience.org/library/papers/26546245 | PubMed |
| 4 | 34332564 | Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018). | BMC Cancer | 2021 | https://conductscience.org/library/papers/34332564 | PubMed |
| 5 | 38762324 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38762324 | PubMed |
| 6 | 20634209 | Tubal ligation and the risk of ovarian cancer: review and meta-analysis. | Hum Reprod Update | 2011 | https://conductscience.org/library/papers/20634209 | PubMed |
| 7 | 38642570 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38642570 | PubMed |
| 8 | 33168565 | Treatment of epithelial ovarian cancer. | BMJ | 2020 | https://conductscience.org/library/papers/33168565 | PubMed |
| 9 | 32031879 | Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/32031879 | PubMed |
| 10 | 38606827 | Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT). | J Gynecol Oncol | 2024 | https://conductscience.org/library/papers/38606827 | PubMed |
| 11 | 32981178 | A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32981178 | PubMed |
| 12 | 38582094 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38582094 | PubMed |
| 13 | 25800123 | A systematic review and meta-analysis of physical activity and endometrial cancer risk. | Eur J Epidemiol | 2015 | https://conductscience.org/library/papers/25800123 | PubMed |
| 14 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 15 | 32472674 | Transiently increased risk of breast cancer after childbirth: implications for fertility treatments and surrogacy. | Hum Reprod | 2020 | https://conductscience.org/library/papers/32472674 | PubMed |
| 16 | 38762327 | Findings from the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38762327 | PubMed |
| 17 | 36460337 | Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/36460337 | PubMed |
| 18 | 38081139 | NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. | J Natl Compr Canc Netw | 2023 | https://conductscience.org/library/papers/38081139 | PubMed |
| 19 | 34233747 | Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. | Biomark Res | 2021 | https://conductscience.org/library/papers/34233747 | PubMed |
| 20 | 32513227 | The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32513227 | PubMed |
Cited by142
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938830 | Beyond Platinum Resistance: Reconsidering Platinum Sensitivity as a Dynamic Phenotype in Ovarian Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938830 | PubMed |
| 42935697 | Global, Regional, and National Burden of Ovarian Cancer Among Women of Reproductive Age, 1990-2021, with Projections to 2040: A Global Burden of Disease Study 2021 Analysis. | Int J Womens Health | 2026 | https://conductscience.org/library/papers/42935697 | PubMed |
| 42920161 | Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment. | Arch Public Health | 2026 | https://conductscience.org/library/papers/42920161 | PubMed |
| 42910745 | Exploring Vitamin D Metabolism in Gynaecological Malignancies: Redox-Dependent and Redox-Independent Anticancer Mechanisms From Preclinical Models to Clinical Evidence. | Cancer Med | 2026 | https://conductscience.org/library/papers/42910745 | PubMed |
| 42908789 | Global, regional and national cancer burden and trends of middle-aged and older populations: a GBD 2021-based analysis, prediction and prevention. | Front Oncol | 2026 | https://conductscience.org/library/papers/42908789 | PubMed |
| 42830779 | Character strengths, psychological distress, anxiety, and depression in adolescents and young adults with gynecologic cancer: A network analysis. | Asia Pac J Oncol Nurs | 2026 | https://conductscience.org/library/papers/42830779 | PubMed |
| 42807817 | HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807817 | PubMed |
| 42752778 | Burden of cancer in China from 1990 to 2023 and projections to 2050. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42752778 | PubMed |
| 42713453 | The use of MRI in the diagnosis of ovarian cancer. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42713453 | PubMed |
| 42682456 | Virtual MR elastography and continuous-time random walk for predicting Ki-67 status in cervical cancer: a preliminary study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42682456 | PubMed |
| 42680981 | Worldwide changes in the burden of deciduous and permanent tooth caries and periodontal disease in children and adolescents aged 0-19 years from 1990 to 2021. | Clin Oral Investig | 2026 | https://conductscience.org/library/papers/42680981 | PubMed |
| 42676940 | Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42676940 | PubMed |
| 42635979 | CHST1 Drives Immunotherapy Resistance in Triple-Negative Breast Cancer by Orchestrating an Immunosuppressive Microenvironment via the NKRF-CCL20-Macrophage Axis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42635979 | PubMed |
| 42625591 | Female cancers in adolescent and young adult women: global inequities and 2050 burden estimates from GLOBOCAN 2022. | Front Oncol | 2026 | https://conductscience.org/library/papers/42625591 | PubMed |
| 42621676 | The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/42621676 | PubMed |
| 42597475 | Actin-related protein 2/3 complex subunit 1B promotes cervical cancer cell tumorigenesis in vitro and in vivo. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42597475 | PubMed |
| 42568605 | COVID-19 vaccination rates as a proxy for health system resilience: implications of development disparities for cervical cancer control during the pandemic. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42568605 | PubMed |
| 42504307 | Suppressing M2 Macrophage Polarization by Glycine Combined with β-Elemene via the IL-6/JAK2/STAT3 Signaling Pathway to Inhibit Triple-Negative Breast Cancer Progression. | Breast Cancer (Dove Med Press) | 2026 | https://conductscience.org/library/papers/42504307 | PubMed |
| 42500684 | Single-cell and spatial profiling reveal an IL-10-associated iCAF-M2 macrophage communication axis in high-grade serous ovarian cancer ascites. | Front Immunol | 2026 | https://conductscience.org/library/papers/42500684 | PubMed |
| 42474716 | Deep learning reconstruction versus conventional parallel imaging for sagittal T2-weighted MRI in cervical cancer: a comparison of acceleration factors. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/42474716 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39794860
GET https://conductscience.org/api/papers/v1/39794860/references?page=2